WINTER HAVEN, Fla. (January 20, 2016)—3B Medical has made a major commitment to allocate a significant portion of its profits to fund research into proof-of-concept studies in use of adipose derived autologous mesenchymal stem cells.
"We spend a lot of resources treating the symptoms of diseases, and not enough trying to target the actual causes. The use of autologous stem cells in regenerative medicine shows considerable promise in changing so many lives. That has always been the core mission of 3B.” said Thomas Thayer, Sr., President, "We are going to lead the way by committing a portion of our resources to try and bring some of this technology to market".
Visit 3bmedical.com for more information.